CIK 0001370053 · Non-accelerated filer<br>Smaller reporting company
ANAPTYSBIO, INC
Sign in to watch- Ticker
- ANAB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 203828755
- Phone
- 858-362-6295
- Business address
- 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
- Former names
- ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $249,372
- in 1 filing, $249K under 10b5-1 plans
Net −$249,372. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-15 | Ware J. Anthony Director | Option exercise · Restricted Stock Unit | −3,900 | 0 | ||
| 2024-06-15 | Orwin John A Director | Option exercise | +2,035 | 2,035 | ||
| 2024-06-15 | Orwin John A Director | Option exercise · Restricted Stock Unit | −2,035 | 0 | ||
| 2024-06-15 | RENTON HOLLINGS Director | Option exercise | +3,900 | 3,900 | ||
| 2024-06-15 | RENTON HOLLINGS Director | Option exercise · Restricted Stock Unit | −3,900 | 0 | ||
| 2024-06-15 | Jain Rita Director | Option exercise | +4,534 | 4,534 | ||
| 2024-06-15 | Jain Rita Director | Option exercise · Restricted Stock Unit | −3,234 | 0 | ||
| 2024-06-15 | Jain Rita Director | Option exercise · Restricted Stock Unit | −1,300 | 0 | ||
| 2024-05-22 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,500 | $23.72 | $36K | 964 |
| 2024-03-26 | Faga Daniel CEO | Shares withheld for taxes | −347,441 | $21.60 | $7.5M | 401,646 |
| 2024-03-25 | Faga Daniel CEO | Sale | −3,000 | $21.42 | $64K | 749,087 |
| 2024-03-22 | Faga Daniel CEO | Sale | −145,940 | $22.78 | $3.3M | 752,087 |
| 2024-02-16 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option exercise 10b5-1 | +5,000 | $14.02 | $70K | 8,240 |
| 2024-02-16 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Sale 10b5-1 | −5,000 | $25.00 | $125K | 3,240 |
| 2024-02-16 | LOUMEAU ERIC J CHIEF LEGAL OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −5,000 | 78,000 | ||
| 2024-01-30 | MULROY DENNIS CHIEF FINANCIAL OFFICER | Sale | −3,065 | $23.63 | $72K | 964 |
| 2024-01-08 | Lizzul Paul F. Chief Medical Officer | Sale | −2,554 | $21.81 | $56K | 10,118 |
| 2024-01-06 | Lizzul Paul F. Chief Medical Officer | Option exercise | +6,145 | 12,672 | ||
| 2024-01-06 | Lizzul Paul F. Chief Medical Officer | Option exercise · Restricted Stock Unit | −6,145 | 18,435 |
Page 17 of 17 · 339 trades